These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10396315)

  • 1. [Gemcitabine in the treatment of non-small cell lung cancer for elderly patients].
    Furuse K
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):890-7. PubMed ID: 10396315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of gemcitabine in the treatment of patients with non-small cell lung cancer: a multicenter phase II study.
    Yokoyama A; Nakai Y; Yoneda S; Kurita Y; Niitani H
    Anticancer Drugs; 1997 Jul; 8(6):574-81. PubMed ID: 9300571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.
    Anderson H; Lund B; Bach F; Thatcher N; Walling J; Hansen HH
    J Clin Oncol; 1994 Sep; 12(9):1821-6. PubMed ID: 8083706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study.
    Takada M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Fukuoka M
    Cancer Chemother Pharmacol; 1998; 41(3):217-22. PubMed ID: 9443638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)].
    Fukuoka M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Taguchi T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1825-32. PubMed ID: 8937493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A late phase II study of LY188011 (Gemcitabine hydrochloride) in patients with non-small-cell lung cancer. Gemcitabine Cooperative Study Group B for Late Phase II].
    Yokoyama A; Nakai Y; Yoneda S; Kurita Y; Niitani H; Taguchi T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1681-8. PubMed ID: 8886045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.
    Maestu I; Gómez-Aldaraví L; Torregrosa MD; Camps C; Llorca C; Bosch C; Gómez J; Giner V; Oltra A; Albert A
    Lung Cancer; 2003 Dec; 42(3):345-54. PubMed ID: 14644523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
    Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
    Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II studies of gemcitabine for non-small cell lung cancer in Japan].
    Asai G; Fukuoka M
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):884-9. PubMed ID: 10396314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients.
    Gridelli C; De Maio E; Barbera S; Sannicolo M; Piazza E; Piantedosi F; Brancaccio L; Morabito A; Maione P; Renda F; Signoriello G; Perrone F;
    Lung Cancer; 2008 Jul; 61(1):67-72. PubMed ID: 18683299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer.
    Altavilla G; Adamo V; Buemi B; Marabello G; Maisano R; Lupo G; Bene A; Bellocco G
    Anticancer Res; 2000; 20(5C):3675-8. PubMed ID: 11268438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer.
    Shepherd FA; Abratt RP; Anderson H; Gatzemeier U; Anglin G; Iglesias J
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-50-S7-55. PubMed ID: 9194481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO).
    Tibaldi C; Ricci S; Russo F; Bernardini I; Galli L; Chioni A; Orlandini C; Grosso AM; Pegna AL; Fabbri A; Innocenti F; Ferrari K; Tognarini L; Conte PF; Falcone A;
    Lung Cancer; 2005 Apr; 48(1):121-7. PubMed ID: 15777979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer.
    Cho KH; Song YB; Choi IS; Cho EH; Choi JW; Ahn YM; Roh YH; Nam SH; Kim BS
    Jpn J Clin Oncol; 2006 Jan; 36(1):50-4. PubMed ID: 16418187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
    Gridelli C; Cigolari S; Gallo C; Manzione L; Ianniello GP; Frontini L; Ferraù F; Robbiati SF; Adamo V; Gasparini G; Novello S; Perrone F;
    Lung Cancer; 2001; 31(2-3):277-84. PubMed ID: 11165408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy.
    Cappuzzo F; Novello S; De Marinis F; Selvaggi G; Scagliotti GV; Barbieri F; Maur M; Papi M; Pasquini E; Bartolini S; Marini L; Crinò L
    Lung Cancer; 2006 Jun; 52(3):319-25. PubMed ID: 16630670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.
    Gajra A; Mehdi SA; Kirshner J; Newman N; Graziano SL
    Lung Cancer; 2001 May; 32(2):189-96. PubMed ID: 11325490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancer.
    Martoni A; Di Fabio F; Guaraldi M; Piana E; Ramini R; Lelli G; Palomba G; Artioli F; Bandieri E; Robustelli Della Cuna G; Preti P
    Am J Clin Oncol; 2001 Dec; 24(6):614-7. PubMed ID: 11801766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.